BAX has an annual revenue baseline of $11.2B, latest revenue marker of $2.7B Q1 2026, annual net income of -$957M and cash of $2.02B. The thesis depends on revenue durability, margins, cash conversion and balance-sheet discipline.
Baxter: the hospital-products reset has to turn scale into cleaner earnings
NYSEBAXCoverage BootstrapBaxter International Inc.
Thesis summary
BAX has an annual revenue baseline of $11.2B, latest revenue marker of $2.7B Q1 2026, annual net income of -$957M and cash of $2.02B. The thesis depends on revenue durability, margins, cash conversion and balance-sheet discipline.
View article
Discuss the thesis
0 commentsCommenting requires active membershipBecome a member
Attack the thesis, not the person.Add evidence when challenging claims.No pump, spam, or low-effort comments.
No comments yet. Start the discussion with evidence, a question, or a bear case.